For this reason, it has been suggested as an effective target for immunotherapy.28 Additionally, Zhang et al29 demonstrated the expression of the eEF2 protein in prostatic carcinoma tissue by immunohistochemistry. This evidence concerns the gene EEF2 and prostate carcinoma.